| Authors: |
Weiss L; Department of Medicine III, LMU Klinikum, University of Munich, Munich, Germany. Electronic address: Lena.Weiss@med.uni-muenchen.de., Stintzing S; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin und Humboldt-Universität zu Berlin, Department of Hematology, Oncology and Cancer Immunology, Berlin, Germany., Stahler A; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin und Humboldt-Universität zu Berlin, Department of Hematology, Oncology and Cancer Immunology, Berlin, Germany., Benedikt Westphalen C; Department of Medicine III, LMU Klinikum, University of Munich, Munich, Germany; Comprehensive Cancer Center Munich, LMU Klinikum, University of Munich, Munich, Germany., von Weikersthal LF; Praxis für Hämatologie/Onkologie, MVZ St. Marien, Amberg, Germany., Decker T; Oncological Practice, Ravensburg, Germany., Kiani A; Department of Hematology and Oncology, Klinikum Bayreuth GmbH, Bayreuth, Germany and Comprehensive Cancer Center-EMN, Erlangen, Germany., Vehling-Kaiser U; Oncological Practice, Landshut, Germany., Al-Batran SE; Institute of Clinical Cancer Research at Krankenhaus Nordwest University Cancer Center, Frankfurt, Germany., Heintges T; Department of Medicine II, Rheinlandklinikum Neuss, Neuss, Germany., Lerchenmüller CA; Oncological Practice, Münster, Germany., Kahl C; Department of Haematology and Oncology, Städtisches Klinikum Magdeburg, Magdeburg, Germany; Department of Haematology, Oncology and Palliative Care, Klinikum Magdeburg gGmbH, Magdeburg, Germany; Department of Hematology, Oncology, and Palliative Care, University of Rostock, Rostock, Germany., Seipelt G; Department of Hematology, Oncology, and Palliative Care, University of Rostock, Rostock, Germany; Oncological Practice, Bad Soden, Germany., Kullmann F; Oncological Practice, Bad Soden, Germany; Department of Medicine I, Klinikum Weiden, Weiden, Germany., Heinrich K; Department of Medicine III, LMU Klinikum, University of Munich, Munich, Germany., Holch JW; Department of Medicine III, LMU Klinikum, University of Munich, Munich, Germany., Alig A; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin und Humboldt-Universität zu Berlin, Department of Hematology, Oncology and Cancer Immunology, Berlin, Germany., Jung A; Department of Medicine I, Klinikum Weiden, Weiden, Germany; Institute of Pathology, University of Munich, Munich, Germany., Modest DP; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin und Humboldt-Universität zu Berlin, Department of Hematology, Oncology and Cancer Immunology, Berlin, Germany., Heinemann V; Department of Medicine III, LMU Klinikum, University of Munich, Munich, Germany; Comprehensive Cancer Center Munich, LMU Klinikum, University of Munich, Munich, Germany. |
